AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 293 min read$DXC

DXC’s (NYSE:DXC) Q3 CY2026 sales beat estimates but stock drops 15.4%

DXC Technology reported Q3 revenue of $3.03B, beating estimates by 1.3%, and adjusted EPS of $0.67, exceeding expectations by 22%. However, the company lowered its full-year revenue and EPS guidance, and margins declined. The stock dropped 15.4% on the news.

Original reporting
finance.yahoo.com
Published Oct 29, 2026, 8:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
DXC’s (NYSE:DXC) Q3 CY2026 sales beat estimates but stock drops 15.4% — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$DXCBearishHigh
01

Why it matters

The combination of beat results and lowered guidance typically leads to a negative market reaction because forward expectations worsen even if the quarter was strong.

02

Market read

Traders should focus on the guidance cut and cash-flow/margin deterioration as the likely drivers of the post-earnings repricing.

03

What to watch

Investors may be over-weighting margin and FCF margin declines without considering one-time items or working-capital timing not detailed in the excerpt.

Relevance 9/10Novelty 9/10Timing: after-hours or next-session repricing following the Q3 results and guidance cut

Background

DXC’s Q3 print included both a beat versus consensus and a simultaneous reduction in full-year guidance.

Company-level read

Ticker impact

$DXCBearishHigh confidence
Context

DXC reported Q3 CY2026 revenue and adjusted EPS beats, but lowered full-year revenue and adjusted EPS guidance, driving a sharp stock drop.

Expected impact

Likely further pressure as the market reprices DXC around the lowered full-year revenue and adjusted EPS guidance and weaker operating/FCF margins.

Evidence & confidence

The article provides both upside (revenue and EPS beats) and downside (full-year guidance reductions plus operating margin and free cash flow margin declines), and the headline notes a large single-day drop.

Market effects

Sector

Signals continued margin and cash-flow pressure in IT services/consulting, potentially raising caution on peers with similar cost structures.

Regional

Primarily US large-cap sentiment impact via a single-name repricing; limited direct spillover implied by the article.

Global

No explicit global macro or cross-border catalyst beyond DXC-specific guidance and performance.

Counterpoint

What could challenge this read

The quarter’s revenue and adjusted EPS beats suggest execution improved near-term, so the guidance cut could be viewed as conservative rather than structural if backlog or demand stabilizes.

Key entities

  • company
    DXC Technology

    Subject of the article, reporting Q3 CY2026 results and cutting full-year revenue and adjusted EPS guidance.

Read at source← All news

StoryDXC Technology reports Q2 FY27 results with revenue decline and FY27 guidance

Also covered by

4 outlets

Related articles

OCT 29
$DXCHighAI 9/10

DXC Q2 FY27 slides show earnings beat, but guidance cut sparks selloff

DXC Technology (NYSE:DXC) reported Q2 FY27 earnings beating estimates with $0.67 EPS and $3.03B revenue, but shares fell 17% after-hours due to weak bookings, lower guidance, and a 10% drop in total bookings. The company cut its full-year outlook, citing deal timing and conversion challenges. Despite AI and modernization efforts, organic revenue declined 4.0% YoY, and margins shrank. DXC generated $91M in free cash flow but reduced its FY27 EPS guidance to $2.25-$2.50.

investing.com7 min
OCT 29
$DXCMedAI 8/10

DXC Technology earnings beat by $0.12, revenue topped estimates

DXC Technology (NYSE: DXC) reported Q2 EPS of $0.67, beating estimates by $0.12, with revenue at $3.03B, surpassing expectations. The company guided Q3 2027 EPS at $0.55, below consensus, and revenue at $2.98B, also below estimates. For FY 2027, DXC expects EPS of $2.25-$2.50 and revenue of $11.91B-$11.98B, both under analyst forecasts. The stock is up 35.50% over 3 months and 17.70% over 12 months.

investing.com3 min
OCT 29
$DXCHighAI 8/10

DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DXC Technology Reports Second Quarter Fiscal Year 2027 Results • Total revenue for Q2 FY27 of $3.03 billion, down 4.0% YoY, down 4.0% on an organic basis (1) • Q2 FY27 EBIT margin of 2.2%, and adjusted EBIT (2) margin of 6.2% • Q2 FY27 Diluted earnings per share of $

SEC EDGAR 8-K2 min
OCT 29
$DXCHighAI 8/10

DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology reported Q2 FY27 revenue of $3.03B, down 4% YoY. EBIT margin was 2.2%, and adjusted EBIT margin was 6.2%. EPS was $0.15, with non-GAAP EPS at $0.67, down 20.2% YoY. Free cash flow for H1 FY27 was $405M. Bookings were $2.4B, with a 1.0x book-to-bill ratio. The company repurchased $60M in shares and is discussing a possible sale of its insurance business. Guidance for FY27 includes revenue of $11.91B-$11.98B and non-GAAP EPS of $2.25-$2.50.

prnewswire.com2 min
OCT 29
$DXCHighAI 9/10

Total revenue fell 4% year over year; DXC expects organic revenue to drop about 6% next quarter from a year earlier.

DXC Technology reported Q2 FY27 revenue of $7.45 billion, down 4% YoY, with adjusted EBIT margin of 6.2% and non-GAAP EPS of $0.15. The company expects Q3 organic revenue to drop 6% YoY. CEO Raul Fernandez highlighted progress in AI-based solutions. DXC also announced potential sale of its insurance business. Full-year revenue is projected to decline 5-5.5% YoY. (299 characters)

stocktitan.net3 min
OCT 29
$DXCMedAI 8/10

DXC earnings ahead amid $2.4 billion insurance unit sale talks

DXC Technology reports Q2 earnings with analysts expecting EPS of $0.55 and revenue of $2.98B, down YoY but up sequentially. The company is in talks to sell its insurance unit for $2.4B. Analysts have a neutral consensus with a $11.21 price target, implying 30% downside. Investors focus on the sale's impact and DXC's core business stability.

investing.com2 min